Metrovacesa revenue and financials

MVC · BME · EUR

€10.40Change from previous close: +1.76%Absolute change: +€0.18

Close · October 6, 2026

In the fiscal year ended December 2025, Metrovacesa reported revenue of €708.46M (+8.37% year over year). Net income was €56.86M, a net margin of 8.0%.

Annual revenue · 2025: €708.46M
  1. €519.21M2022
  2. €586.46M2023
  3. €653.76M2024
  4. €708.46M2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+8.37%
2025 vs 2024
Net income growth
+257.94%
2025 vs 2024
Net margin
8.0%
2024: 2.4%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets2,2582,4142,5332,514—
Current assets1,8742,0252,1372,106—
Cash and equivalents13084.272.3124—
Short-term investments7.50.752.220.0—
Inventory1,5571,7341,8241,842—
Net property, plant and equipment3.13.84.62.3—
Other intangible assets—0.4———
Long-term investments49.549.149.054.2—
Current liabilities521507555382—
Accounts payable71.371.172.276.2—
Long-term debt254248234273—
Total debt404394438348—
Total liabilities844817847708—
Total equity (incl. minority)1,4141,5971,6851,806—
Retained earnings-205-261-277-256—